folic acid

(redirected from antifolate)
Also found in: Thesaurus, Medical, Legal, Encyclopedia.

fo·lic acid

 (fō′lĭk, fŏl′ĭk)
n.
A yellowish-orange compound, C19H19N7O6, found in nature in the form of various folates or produced synthetically, used as a dietary supplement and to fortify foods, especially wheat flour. Also called folacin.

[Latin folium, leaf; see folium + -ic.]

folic acid

(ˈfəʊlɪk; ˈfɒl-; ˈfəʊleɪt)
n
(Elements & Compounds) any of a group of vitamins of the B complex, including pteroylglutamic acid and its derivatives: used in the treatment of megaloblastic anaemia. Also called: folacin
[C20: from Latin folium leaf; so called because it may be obtained from green leaves]
ˈfolate n, adj

fo′lic ac′id


n.
a water-soluble vitamin that is converted to a coenzyme essential to purine and thymine biosynthesis: deficiency causes a form of anemia.
[1941; < Latin fol(ium) leaf + -ic]

fo·lic acid

(fō′lĭk, fŏl′ĭk)
A vitamin belonging to the vitamin B complex that is important in cell growth and metabolism. It is found especially in green leafy vegetables and fresh fruit. Lack of folic acid can cause anemia because it is necessary for the formation of red blood cells.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.folic acid - a B vitamin that is essential for cell growth and reproduction
B complex, B vitamin, B-complex vitamin, vitamin B, vitamin B complex, B - originally thought to be a single vitamin but now separated into several B vitamins
Translations
acide folique

folic acid

[ˌfəʊlɪkˈæsɪd] Nácido m fólico

folic acid

nFolsäure f

fo·lic ac·id

n. ácido fólico, miembro del complejo de vitaminas B.

folic acid

n ácido fólico
References in periodicals archive ?
Prevalence and patterns of antifolate and chloroquine drug resistance markers in Plasmodium vivax across Pakistan.
Methotrexate (MTX) is an antifolate subclass of antimetabolites.
Females within age range of 50 to 70 years with at least three years of amenorrhea were included while females on medications affecting bone mineralization, steroids, cyclosporine, antifolate drugs, oral contraceptives/hormone replacement therapy, multivitamins and bisphosphonate therapy were excluded.
In a broader way antimalarial drugs are generally categorized into different groups depending on the stage of the plasmodium life cycle on which they act; Quinoline antimalarials, 4-aminoquinoline series, Antifolate Derivatives and DOXP Reductoisomerase Inhibitors For many years, malaria was treated successfully using chloroquine (CQ) and antifolate derivatives.
Similarly, women with a previous child with NTD, those treated with antifolate medications, obese women, and smokers should also be targeted.
The same result was observed for quinolines, an antifolate, or atovaquone (Table 1).
But there are more subgroups that could benefit from higher doses of folic acid, including women taking antifolate medications such as anti-epileptic drugs, methotrexate, and sulfonamides.
Some patients reported improved symptoms after splenectomy; others showed increased platelet counts following the procedure, making them eligible for further treatment with drugs, such as pralatrexate, an antifolate medication.
These groups include women on antiepileptic drugs or drugs that have antifolate activity, such as sulfonamide and methotrexate, as well as women with some genetic polymorphisms in the folate cycle.
Antibiotics Sensitivities Class Drug Literature Patient Isolate MIC Interpretation Aminoglycoside Amikacin S <=2 S Gentamicin S <=1 S Tobramycin S <=1 S Antifolate Sulfonamide S Trimethoprim S Trimethoprim/ S <=1 S Sulfonamide Penicilins Ampicillin/ S,I >=32 R Sulbactam Amoxicillin R Penacillin R Cephalosporins 1st Cefazolin R >=64 R Generation Cephalothin R 2nd Cefoxitin R >=64 R Generation 3rd Ceftazidime S <=1 S Generation Ceftriaxone S <=1 S 4th Cefepime S <=1 S Generation Carbapenems Imipenum S <=1 S Meropenem S <=0.
Antifolate antimalarial resistance in southeast Africa: A population-based analysis.
The company added that the reduction in R&D costs is primarily due to the completion of multiple studies in both the droxidopa and antifolate development programmes in 2012.